276 related articles for article (PubMed ID: 23257828)
1. Autocrine functions of VEGF in breast tumor cells: adhesion, survival, migration and invasion.
Perrot-Applanat M; Di Benedetto M
Cell Adh Migr; 2012; 6(6):547-53. PubMed ID: 23257828
[TBL] [Abstract][Full Text] [Related]
2. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin.
Luo M; Hou L; Li J; Shao S; Huang S; Meng D; Liu L; Feng L; Xia P; Qin T; Zhao X
Cancer Lett; 2016 Apr; 373(1):1-11. PubMed ID: 26805761
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms.
Chakraborty G; Jain S; Kundu GC
Cancer Res; 2008 Jan; 68(1):152-61. PubMed ID: 18172307
[TBL] [Abstract][Full Text] [Related]
4. FGF9-induced ovarian cancer cell invasion involves VEGF-A/VEGFR2 augmentation by virtue of ETS1 upregulation and metabolic reprogramming.
Bhattacharya R; Ray Chaudhuri S; Roy SS
J Cell Biochem; 2018 Nov; 119(10):8174-8189. PubMed ID: 29904943
[TBL] [Abstract][Full Text] [Related]
5. Enhancing integrin function by VEGF/neuropilin signaling: implications for tumor biology.
Goel HL; Mercurio AM
Cell Adh Migr; 2012; 6(6):554-60. PubMed ID: 23076131
[TBL] [Abstract][Full Text] [Related]
6. Cystathionine‑γ‑lyase promotes the metastasis of breast cancer via the VEGF signaling pathway.
Wang L; Shi H; Liu Y; Zhang W; Duan X; Li M; Shi X; Wang T
Int J Oncol; 2019 Aug; 55(2):473-487. PubMed ID: 31173185
[TBL] [Abstract][Full Text] [Related]
7. Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro.
Weigand M; Hantel P; Kreienberg R; Waltenberger J
Angiogenesis; 2005; 8(3):197-204. PubMed ID: 16328160
[TBL] [Abstract][Full Text] [Related]
8. Autocrine human growth hormone promotes tumor angiogenesis in mammary carcinoma.
Brunet-Dunand SE; Vouyovitch C; Araneda S; Pandey V; Vidal LJ; Print C; Mertani HC; Lobie PE; Perry JK
Endocrinology; 2009 Mar; 150(3):1341-52. PubMed ID: 18974274
[TBL] [Abstract][Full Text] [Related]
9. VEGF-neuropilin-2 signaling promotes stem-like traits in breast cancer cells by TAZ-mediated repression of the Rac GAP β2-chimaerin.
Elaimy AL; Guru S; Chang C; Ou J; Amante JJ; Zhu LJ; Goel HL; Mercurio AM
Sci Signal; 2018 May; 11(528):. PubMed ID: 29717062
[TBL] [Abstract][Full Text] [Related]
10. αB-crystallin, an effector of unfolded protein response, confers anti-VEGF resistance to breast cancer via maintenance of intracrine VEGF in endothelial cells.
Ruan Q; Han S; Jiang WG; Boulton ME; Chen ZJ; Law BK; Cai J
Mol Cancer Res; 2011 Dec; 9(12):1632-43. PubMed ID: 21984182
[TBL] [Abstract][Full Text] [Related]
11. Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells.
Ciccone V; Terzuoli E; Donnini S; Giachetti A; Morbidelli L; Ziche M
J Exp Clin Cancer Res; 2018 Dec; 37(1):311. PubMed ID: 30541574
[TBL] [Abstract][Full Text] [Related]
12. VEGF-initiated angiogenesis and the uPA/uPAR system.
Breuss JM; Uhrin P
Cell Adh Migr; 2012; 6(6):535-615. PubMed ID: 23076133
[TBL] [Abstract][Full Text] [Related]
13. The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis.
Yee AJ; Akens M; Yang BL; Finkelstein J; Zheng PS; Deng Z; Yang B
Breast Cancer Res; 2007; 9(4):R47. PubMed ID: 17662123
[TBL] [Abstract][Full Text] [Related]
14. Oral administration of pyrrolidine dithiocarbamate (PDTC) inhibits VEGF expression, tumor angiogenesis, and growth of breast cancer in female mice.
Gu JW; Young E; Busby B; Covington J; Johnson JW
Cancer Biol Ther; 2009 Mar; 8(6):514-21. PubMed ID: 19242105
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor: Evidence for autocrine signaling in hepatocellular carcinoma cell lines affecting invasion.
Sharma BK; Srinivasan R; Chawla YK; Chakraborti A
Indian J Cancer; 2016; 53(4):542-547. PubMed ID: 28485347
[TBL] [Abstract][Full Text] [Related]
16. OVA66 promotes tumour angiogenesis and progression through enhancing autocrine VEGF-VEGFR2 signalling.
Song F; Chen Q; Rao W; Zhang R; Wang Y; Ge H; Wei Q
EBioMedicine; 2019 Mar; 41():156-166. PubMed ID: 30833190
[TBL] [Abstract][Full Text] [Related]
17. Novel hexahydrocannabinol analogs as potential anti-cancer agents inhibit cell proliferation and tumor angiogenesis.
Thapa D; Lee JS; Heo SW; Lee YR; Kang KW; Kwak MK; Choi HG; Kim JA
Eur J Pharmacol; 2011 Jan; 650(1):64-71. PubMed ID: 20950604
[TBL] [Abstract][Full Text] [Related]
18. The transcription factor GATA1 and the histone methyltransferase SET7 interact to promote VEGF-mediated angiogenesis and tumor growth and predict clinical outcome of breast cancer.
Zhang Y; Liu J; Lin J; Zhou L; Song Y; Wei B; Luo X; Chen Z; Chen Y; Xiong J; Xu X; Ding L; Ye Q
Oncotarget; 2016 Mar; 7(9):9859-75. PubMed ID: 26848522
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of breast carcinoma and trophoblast cell invasiveness by vascular endothelial growth factor.
Fitzpatrick TE; Lash GE; Yanaihara A; Charnock-Jones DS; Macdonald-Goodfellow SK; Graham CH
Exp Cell Res; 2003 Feb; 283(2):247-55. PubMed ID: 12581744
[TBL] [Abstract][Full Text] [Related]
20. Impact of ER520, a candidate of selective estrogen receptor modulators, on in vitro cell growth, migration, invasion, angiogenesis and in vivo tumor xenograft of human breast cancer cells.
Wang L; Wang Y; Du H; Jiang Y; Tang Z; Liu H; Xiang H; Xiao H
Cancer Chemother Pharmacol; 2015 Dec; 76(6):1247-57. PubMed ID: 26464351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
